Trial: 201703028

Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors

Phase

II

Principal Investigator

Tan, Benjamin

Disease Site

Anus; Breast; Colon; Esophagus; Eye and Orbit; Kidney; Larynx; Lip, Oral Cavity and Pharynx; Liver; Lung; Melanoma, Skin; Other Digestive Organ; Other Urinary; Pancreas; Prostate; Rectum; Small Intestine; Stomach; Thyroid; Urinary Bladder

Learn more about this study at: clinicaltrials.gov